SBIR/STTR Research Award
TRANSLOCATION ASSAY BY PCR AMPLIFICATION IN SITU
Award amount
$48,557Program and phase
SBIR · Phase IAward year
1992Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- ONCOGENE SCIENCE, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
POLYMERASE CHAIN REACTION (PCR) AMPLIFICATION AND DETECTION IN SITY HAS BEEN DESCRIBED FOR THE HUMAN PAPILLOMAVIRUS (HPV 16, 1) AND VISNA VIRUS (2). USE OF PCR TECHNIQUES IS EXTREMELY POWERFUL YET HAS SOME DISADVANTAGES. PCR AMPLIFICATION IN SITU CIRCUMVENTS SOME OF THESE AND ALSO ALLOWS CORRELATION OF CELL MORPHOLOGY WITH MRNA EXPRESSION OR PRESENCE OF A TRANSLOCATION. IN PHASE I, METHODS OF PCR AMPLIFICATION IN SITY FOR CANCER RESEARCH, USING FORMALIN FIXED, PARAFFIN EMBEDDED CELL LINES WILL BE OPTIMIZED. THESE TARGETS WILL BE THE T(14; 18) BC12 (MBR)/IGH TRANSLOCATION USING SU-DHL-6 CELLS, AND RNA-PCR IN SITU FOR THE T(9; 22) BCR/ABL TRANSLOCATION, USING K562 CELLS. THE HL-60 CELL LINE WILL BE USED AS A NEGATIVE CONTROL FOR MIXING EXPERIMENTS. IN PHASE II AND III, ASSAYS FOR THE T(14; 18) BC12 (MCR)/IGH T(9; 22) BCR/ABL (ALL), T(1; 19) E2A/PRL-PBX, T(15; 17)MYL/RARA, AND T (6; 9) DEK/CAN TRANSLOCATION WILL BE DEVELOPED AND COMMERCIALIZED.
Technology keywords
Not reported